Tobramycin inhalation powder for the treatment of pulmonary Pseudomonas aeruginosa infection in patients with cystic fibrosis: a review based on clinical evidence.

The analysis by gender showed a trend toward greater improvements in FEV 1 % predicted with TIP in male patients than in female patients, and in patients with FEV 1 % predicted <50% compared with those with FEV 1 % predicted >50% (10.1% versus −0.5%). 48 In the analysis by age, patients were categorized into three groups [⩾6 to <13 years (children), ⩾13 to <20 years (adolescents), and ⩾20 years (adults)].

also in 53,322 other papers